Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...

Our genomes are filled with errors that were once impossible to correct. But in CRISPR, we finally found an extraordinarily ...

Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK Programme spans neurological disorders, sensory ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in ...

Stem cell IVF could enable same-sex couples and single parents to have genetically related children. It’s time to think ...

Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will ...

Overview: Emerging technologies in 2026 are pushing the boundaries of what’s possible across industries, from healthcare to entertainment.They blend computing p ...

Cathie Wood predicts stock market golden age through 2026 with 6-8% GDP growth. ARK Innovation ETF returned 35% in 2025 vs ...

Microbiologist Detmer Sipkema has been awarded an ENW-M grant from the Netherlands Organisation for Scientific Research (NWO) for innovative, ...

Ever picked up a book and felt that strange chill when fiction becomes reality? Some authors seem to possess an uncanny gift, ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...

Rapid policy shifts, sustainability targets, and process-level innovations have fundamentally reshaped the global biofuel ...